首页> 外文会议>World Congress on Fertility and Sterility >An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen

【24h】

An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

This phase Illb, multicenter, open-label, randomized study, compared cycle control, quality of life, safety, and contraceptive efficacy of CTR 25, Alesse?, and Ortho Tri-Cyclen at seven sites across Canada, 202 sexually active women were randomized to either CTR 25, Alesse, or Ortho Tri-Cyclen foi six cycles of 28 days each The three regimens were found to have similar cycle control, quality of life, contraceptive efficacy, and safety This demonstrates that two 20 meg ethinyl estradiol (EE) preparations have an equivalent profile to a 35 meg ethinyl estradiol preparation.

机译：该阶段ILLB，多中心，开放标签，随机研究，比较循环控制，生命质量，安全性，安全性和避孕药的CTR 25，Alesse？，和在七个地点在加拿大的七个地点，202例性活跃的女性随机分组对于CTR 25，Alesse或Ortho三环FOI六个循环为28天，每个三个方案被发现具有类似的循环控制，生活质量，避孕药的功效和安全性，这证明了两种20兆乙基雌二醇（EE）制剂具有相当于35mmg乙炔雌二醇制剂的型材。

著录项

来源
《World Congress on Fertility and Sterility》|2004年||共4页
会议地点
作者
Victoria Davis; Brian Hauck; Sheila Dunn; Marie Ann Jamieson; Robert Lea; Lucie Lemieux;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类不育症;
关键词
Oral contraceptive; Cycle control; Efficacy; Quality of life;

机译：口服避孕;循环控制;疗效;生活质量;

相似文献

外文文献
中文文献
专利

1. A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase [J] . Manning Donald C., Gimbel Joseph, Wertz Robert, Pain medicine : . 2017,第3期

机译：Lenalal族疼痛中Lenalidomide在Lenalal突出疼痛中的一期随机，双盲，安慰剂控制的安全性和疗效研究A II期随机，双盲，安慰剂对照安全性和Lenalidomide的疗效研究在腰部疼痛的长期开放标签扩展阶段
2. Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study) [J] . Ji LiNong, Chen LiMing, Wang YanGang, Advances in therapy. . 2019,第6期

机译：研究方案的前瞻性，多中心，随机，开放标签，并联群临床试验比较无针胰岛素注射器的功效和安全性和传统的胰岛素笔控制中国2型糖尿病患者血糖浓度（免费学习）
3. FUNCTION, WORK PRODUCTIVITY, AND QUALITY OF LIFE MEASURES IN A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, 12-WEEK STUDY OF THE SAFETY AND EFFICACY OF SOLRIAMFETOL (JZP-110) FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA [J] . Drake C., Bogan R., Benes H., Sleep medicine . 2017,第期

机译：功能，工作生产力和生活质量措施在3阶段，随机，安慰剂控制，双盲，多中心，12周的Solriamfetol（JZP-110）的安全性和有效性，用于治疗过度困倦阻塞性睡眠呼吸暂停的患者
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
6. A multicenter randomized open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly the combination of etanercept 25 mg twice weekly and acitretin and acitretin alone in patients with moderate to severe psoriasis [O] . Joo-Heung Lee, Jai-Il Youn, Tae-Yoon Kim, 2016

机译：一项多中心随机开放标签的先导试验评估中度至重度牛皮癣患者每周两次两次每周两次每次两次25mg依那西普每周两次两次25mg依那西普和阿曲汀的疗效和安全性
7. A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis [O] . 2016

机译：一项多中心，随机，开放标签的先导试验，评估中度至重度牛皮癣患者每周两次，两次每周两次，每次两次25mg依那西普，每周两次两次，25mg依那西普和阿曲汀的疗效和安全性

An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen

摘要

著录项

相似文献

相关主题

期刊订阅